Position in MDWD
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$2,093,671
+$129,583 QoQ
Shares Held
129,961
+22.1% QoQ
Ownership
1.01%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDWD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARK Investment Management LLC holds $1,308,181,852 across 17 Biotechnology names. MDWD ranks #14 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,313,623 | $538,189,046 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
12,133,433 | $289,139,708 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
14,509,247 | $186,008,546 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
40,212,769 | $123,453,200 | |
| 5 | ABSI |
Absci Corp
|
13,726,169 | $41,178,507 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
1,721,135 | $26,677,592 | |
| 7 | PRME |
Prime Medicine, Inc.
|
6,246,827 | $21,738,957 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
288,716 | $21,679,684 |
All Filings in MDWD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,093,671 | 129,961 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,964,088 | 106,397 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,745,759 | 96,879 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,833,757 | 94,670 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,659,553 | 106,930 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,784,378 | 100,246 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,805,891 | 99,994 | Shares | Sole | 2024-10-31 | |
| No filing history on record for this holder in this stock. | ||||||